Hodgkin's Lymphoma;Lymphome de Hodgkin

Cancer/Radiotherapie

Volumn 14, Issue SUPPL. 1, 2010, Pages

  Drouet, F ^a   Cahu, X ^b   Pointreau, Y ^c   Denis, F ^d   Mahe M A ^a  

^a CENTRE RENÉ GAUDUCHEAU   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^c CHU BRETONNEAU   (France)

^d CENTRE JEAN BERNARD   (France)

Author keywords

Atlas; Conformal radiotherapy; Hodgkin's lymphoma; Target volumes

Indexed keywords

ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CARDIOVASCULAR DISEASE; GOLD STANDARD; HODGKIN DISEASE; HUMAN; IRRADIATION; LONG TERM CARE; METASTASIS; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; FRANCE; HODGKIN DISEASE; HUMANS; INCIDENCE; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; TREATMENT OUTCOME;

EID: 78649779160     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(10)70024-X     Document Type: Article

References (54)

1. Aleman B.M.P., van den Belt-Dusebout A.W., Klokman W.J., Van't Veer M.B., Bartelink H., van Leeuwen F.E. Long-term cause-specific mortality of patients treated for Hodgkin's disease. J Clin Oncol 2003, 21:3431-3439.
2. Ambinder R.F. Epstein-barr virus and hodgkin lymphoma. Hematology Am Soc Hematol Educ Program 2007, 204-209.
3. Bar Ad.V., Paltiel O., Glatstein E. Radiotherapy for early-stage Hodgkin's lymphoma: a 21st century perspective and review of multiple randomized clinical trials. Int J Radiat Oncol Biol Phys 2008, 72:1472-1479.
4. Brusamolino E., Bacigalupo A., Barosi G., Biti G., Gobbi P.G., Levis A., et al. Classical Hodgkin's lymphoma in adults: guidelines of the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation on initial work-up, management, and follow-up. Haematologica 2009, 94:550-565.
5. Caporaso N.E., Goldin L.R., Anderson W.F., Landgren O. Current insight on trends, causes, and mechanisms of Hodgkin's lymphoma. Cancer J 2009, 15:117-123.
6. Carmel R.J., Kaplan H.S. Mantle irradiation in Hodgkin's disease: an analysis of technique, tumor eradication, and complications. Cancer 1976, 37:2813-2825.
7. Connors J.M. State-of-the-art therapeutics: Hodgkin's lymphoma. J Clin Oncol 2005, 23:6400-6408.
8. Cosset J.M., Henry-Amar M., Meerwaldt J.H. Long-term toxicity of early stages of Hodgkin's disease therapy: the EORTC experience. EORTC Lymphoma Cooperative Group. Ann Oncol 1991, 2:77-82.
9. Cosset J.M., Mauch P.M. The role of radiotherapy for early stage Hodgkin's disease: limitations and perspectives. Ann Oncol 1998, 9(Suppl 5):S57-S62.
10. Depil S., Moralès O., Auriault C. Maladie de Hodgkin et virus d'Epstein-Barr: physiopathologie et perspectives thérapeutiques. Ann Biol Clin 2004, 62:639-648.
11. Diehl V., Thomas R.K., Re D. Part II: Hodgkin's lymphoma -- diagnosis and treatment. Lancet Oncol 2004, 5:19-26.
12. Eich H.T., Müller R., Engenhart-Cabillic R., Lukas P., Schmidberger H., Staar S., et al. Involved-node radiotherapy in early-stage Hodgkin's lymphoma: definition and guidelines of the German Hodgkin Study Group (GHSG). Strahlenther Onkol 2008, 184:406-410.
13. Evens A.M., Hutchings M., Diehl V. Treatment of Hodgkin lymphoma: the past, present, and future. Nat Clin Pract Oncol 2008, 5:543-556.
14. Favier O., Heutte N., Stamatoullas-Bastard A., Carde P., Van't Veer M.B., Aleman B.M.P., et al. Survival after Hodgkin lymphoma: causes of death and excess mortality in patients treated in 8 consecutive trials. Cancer 2009, 115:1680-1691.
15. Ferme C. Lymphome de Hodgkin: traitement des stades localisés susdiaphragmatiques. Oncologie 2008, 10:303-306.
16. Girinsky T., van der Maazen R., Specht L., Aleman B., Poortmans P., Lievens Y., et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. Radiother Oncol 2006, 79:270-277.
17. Girinsky T., Ghalibafian M. Radiotherapy of hodgkin lymphoma: indications, new fields, and techniques. Semin Radiat Oncol 2007, 17:206-222.
18. Girinsky T., Ghalibafian M., Bonniaud G., Bayla A., Magne N., Ferreira I., et al. Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?. Radiother Oncol 2007, 85:178-186.
19. Girinsky T., Specht L., Ghalibafian M., Edeline V., Bonniaud G., Van Der Maazen R., et al. The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines. Radiother Oncol 2008, 88:202-210.
20. Girinsky T., Ghalibafian M., Paumier A. Évolution et dilemmes dans les traitements du lymphome de Hodgkin. Cancer Radiother 2009, 13:479-481.
21. Cancer Radiother 2008, 12:143-313. Guide des procédures de radiothérapie externe 2007.
22. Gustavsson A., Osterman B., Cavallin-Ståhl E. A systematic overview of radiation therapy effects in Hodgkin's lymphoma. Acta Oncol 2003, 42:589-604.
23. Hancock S.L., Hoppe R.T. Long-term complications of treatment and causes of mortality after Hodgkin's disease. Semin Radiat Oncol 1996, 6:225-242.
24. Hoppe R.T. Hodgkin's disease: complications of therapy and excess mortality. Ann Oncol 1997, 8(Suppl 1):115-118.
25. Hoppe R.T. The John Ultmann Lecture -- the role of radiation therapy in the treatment of Hodgkin's disease: past, present, and future. Eur J Haematol 2005, 75(1Suppl 66):14-20.
26. Hoppe R.T. Hodgkin's lymphoma: the role of radiation in the modern combined strategies of treatment. Hematol Oncol Clin North Am 2007, 21:915-927.
27. Jaffe E.S., Harris N.L., Stein H., Isaacson P.G. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood 2008, 112:4384-4399.
28. Klimm B., Engert A. Combined modality treatment of Hodgkin's lymphoma. Cancer J 2009, 15:143-149.
29. Lagrange J.L., Kirova Y., Le Bourgeois J.P., Cosset J.M. Maladie de Hodgkin: du volume tumoral macroscopique au volume-cible anatomoclinique, données acquises et problèmes non résolus. Cancer Radiother 2001, 5:650-658.
30. Le Bourgeois J.P., Cosset J.M. Les lymphomes. Radiothér Oncol 1992, 433-444. Hermann, Paris. J.P. Le Bourgeois, J. Chavaudra, F. Eschwege (Eds.).
31. Lee C.K., Aeppli D., Nierengarten M.E. The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin's disease: University of Minnesota experience. Int J Radiat Oncol Biol Phys 2000, 48:169-179.
32. Lee C.K. Evolving role of radiation therapy for hematologic malignancies. Hematol Oncol Clin North Am 2006, 20:471-503.
33. Lee C.K. Radiotherapy for Hodgkin's disease. Technical Basis of Radiation Therapy -- Practical Clinical Applications 2006, 805-835. Springer Verlag, Berlin. S.H. Levitt, J.A. Purdy, C.A. Perez, S. Vijayakumar (Eds.).
34. Mauch P, Ng A, Aleman B, Carde P, Constine L, Diehl V, et al. Report from the Rockefellar Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long-term survivors of Hodgkin's disease: July 9-16, 2003, Bellagio, Italy. Eur J Haematol 2005;66:68-76.
35. Maynadié M, Janoray-Manivet I, Monnereau A, Delafosse P, Troussard X. Estimation de l'incidence et de la mortalité par cancer en France de 1980 à 2005 - Maladie de Hodgkin. INVS 2008. Disponible sur http://www.invs.sante.fr/surveillance/cancers/estimations_cancers/default.htm.
36. Meyer R.M., Ambinder R.F., Stroobants S. Hodgkin's lymphoma: evolving concepts with implications for practice. Hematology Am Soc Hematol Educ Program 2004, 184-202.
37. Michel-Langlet P., Raoul Y., Martin D. Maladie de Hodgkin. Oncologie radiothérapique 1996, 203-210. Masson, Paris. P. Michel-Langlet, Y. Raoul, D. Martin (Eds.).
38. Nautiyal J., Weichselbaum R.R., Vijayakumar S. Radiation therapy techniques in the treatment of Hodgkin's disease. Semin Radiat Oncol 1996, 6:172-184.
39. Ng A.K., Bernardo M.P., Weller E., Backstrand K.H., Silver B., Marcus K.C., et al. Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger. J Clin Oncol 2002, 20:2101-2108.
40. Ng A.K., Mauch P.M. Late effects of Hodgkin's disease and its treatment. Cancer J 2009, 15:164-168.
41. Prosnitz L.R., Brizel D.M., Light K.L. Radiation techniques for the treatment of Hodgkin's disease with combined modality therapy or radiation alone. Int J Radiat Oncol Biol Phys 1997, 39:885-895.
42. Radford J. Limited-stage disease: optimal use of chemotherapy and radiation treatment. Hematology Am Soc Hematol Educ Program 2008, 321-325.
43. Reboul F. Lymphomes malins. Techniques d'irradiaton des cancers 1992, 226-232. Vigot, Paris. J.J. Mazeron, T. Locoche, A. Maugis (Eds.).
44. Reboul F., Goubely Y., Hennequin C. Lymphomes malins. Techniques d'irradiaton des cancers -- La Radiothérapie conformationnelle 2005, 322-334. Maloine, Paris. J.J. Mazeron, A. Maugis, C. Barret, F. Mornex (Eds.).
45. Specht L. FDG-PET scan and treatment planning for early stage Hodgkin lymphoma. Radiother Oncol 2007, 85:176-177. [editorial].
46. Thomas R.K., Re D., Zander T., Wolf J., Diehl V. Epidemiology and etiology of Hodgkin's lymphoma. Ann Oncol 2002, 13(Suppl 4):147-152.
47. Tsang R.W., Hodgson D.C., Crump M. Hodgkin's lymphoma. Curr Probl Cancer 2006, 30:107-158.
48. von der Weid N.X. Adult life after surviving lymphoma in childhood. Support Care Cancer 2008, 16:339-345.
49. Wen B.C., LaFave K. Hodgkin's Lymphoma. Radiation Oncology: An Evidence-Based Approach 2008, 415-428. Springer Verlag, Berlin. J.J. Lu, L.W. Brady (Eds.).
50. Yahalom J., Mauch P. The involved field is back: issues in delineating the radiation field in Hodgkin's disease. Ann Oncol 2002, 13(Suppl 1):79-83.
51. Yahalom J. Changing role and decreasing size: current trends in radiotherapy for Hodgkin's disease. Curr Oncol Rep 2002, 4:415-423.
52. Yahalom J. Transformation in the use of radiation therapy of Hodgkin lymphoma: new concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT). Eur J Haematol 2005, 75(1Suppl 66):90-97.
53. Yahalom J. Don't throw out the baby with the bathwater: on optimizing cure and reducing toxicity in Hodgkin's lymphoma. J Clin Oncol 2006, 24:544-548.
54. Yahalom J. Role of radiation therapy in Hodgkin's lymphoma. Cancer J 2009, 15:155-160.